-
The Mirage of Stability: Challenges of Predicting Disease Activity Over Time in Systemic Lupus Erythematosus (SLE)
Sep 9, 2025, 16:22 PM -
Severity of COVID-19 Pre- and Post-Omicron Emergence in Pediatric Patients: A Global Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Breast Cancer: A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Forecasting the Rise in Direct and Indirect Costs for Lung Cancer on the Example of Poland
Sep 9, 2025, 16:22 PM -
Guidance for Real-World Evidence Generation for the Joint Clinical Assessment Process and Its Implications for Country-Specific HTA Body Acceptability
Sep 9, 2025, 16:22 PM -
Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of Immunotherapies for Perioperative Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Examination of Muscle Activity Among Aesthetic Sports Athletes
Sep 9, 2025, 16:22 PM -
Comparing Individualized Treatment Effect Inference Methods Through a Simulation Study
Sep 9, 2025, 16:22 PM -
Bridging the Gap: Why Cost-Effectiveness Analyses of Congenital Heart Interventions Are Critical for Person-Centered Value-Based Care
Sep 9, 2025, 16:22 PM -
Qualitative Literature Review Exploring the Patient Experience of Shortness of Breath in COPD and Asthma
Sep 9, 2025, 16:22 PM -
Patient Perspectives on the Lifelong Impact of Preterm Birth in Chronic Respiratory Disease Care
Sep 9, 2025, 16:22 PM -
Regulatory Timelines for CMA Medicines In Italy: A Comparative Analysis of Pricing and Reimbursement Procedures
Sep 9, 2025, 16:22 PM -
AI Time and Motion - Analysis of the Accuracy and Efficiency of AI for HTA-Standard SLRs
Sep 9, 2025, 16:22 PM -
Embracing the Long-Term in Disruptive Health Innovations: A Strategic Necessity or a Necessary Evil? Cost Utility of Langerhans Islet Grafting in Unstable Type 1 Diabetes
Sep 9, 2025, 16:22 PM -
Methods for Incidence Progression Estimation in Partitioned Survival Analysis: Does the Chosen Method Matter?
Sep 9, 2025, 16:22 PM -
Real-World Hospital Stays Description and Cost Analysis of Immune Checkpoint Inhibitors (ICIs) Using National PMSI Data in France
Sep 9, 2025, 16:22 PM -
How Does the Source of Transition Probabilities Influence Natural History Simulation and Economic Evaluation in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
Sep 9, 2025, 16:22 PM -
Exploring the Impact of Socioeconomic Factors on COVID-19 Vaccine Hesitancy in India: What Can We Learn From the COVID-19 Pandemic? A Scoping Review
Sep 9, 2025, 16:22 PM -
Implementing SISAQOL Recommendations: Insights From Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
Budget and Time Impact Analysis of Introducing Subcutaneous Pembrolizumab to Patients From Institution HCP and Patient Perspectives in the United States (US)
Sep 9, 2025, 16:22 PM
